Literature DB >> 15868280

Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women.

A L Lauridsen1, P Vestergaard, A P Hermann, C Brot, L Heickendorff, L Mosekilde, E Nexo.   

Abstract

The major transporter of vitamin D metabolites in the circulation is the multifunctional plasma protein Gc, also known as group-specific component, Gc globulin, vitamin D-binding protein, or DBP. There are several phenotypes of Gc, and we examined the influence of Gc phenotype and Gc concentration on vitamin D status. By using isoelectric focusing we identified the Gc phenotype of 595 caucasian recent postmenopausal women enrolled into the Danish Osteoporosis Prevention Study (DOPS). We measured plasma concentration of Gc by immunonephelometry (coefficient of variation [CV] < 5%), 25-hydroxy vitamin D (25OHD) by a competitive protein-binding assay (CV 10%), and 1,25-dihydroxy-vitamin D (1,25(OH)(2)D) by a radioimmunoassay (CV 6--14%), and calculated index as the molar ratio of vitamin concentration divided by Gc concentration. Plasma levels of Gc, 25OHD, 25OHD index, and 1,25(OH)(2)D, but not 1,25(OH)(2)D index, differed significantly between women with different Gc phenotype, being highest in Gc1-1, intermediate in Gc1-2, and lowest in Gc2-2. In multiple regression analysis, Gc concentration was an independent predictor of 1,25(OH)(2)D, whereas Gc phenotype was a significant predictor of 25OHD concentration, even after adjustment for the effects of season, sunbathing habits, skin thickness, use of vitamin supplements, smoking, and body mass index (BMI). Plasma parathyroid hormone (PTH) level did not differ between Gc phenotypes. Despite the fact that more than 60% of the women with Gc phenotype Gc2-2 had plasma 25OHD levels of less than 50 nmol/L none of them had plasma PTH higher than reference limits. Bone mineral content (BMC), Bone mineral density (BMD), and bone markers did not differ between Gc phenotypes. In conclusion, plasma 1,25(OH)(2)D, 25OHD, and 25OHD index are related to Gc phenotype, and we speculate that the thresholds for vitamin D sufficiency differ between Gc phenotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868280     DOI: 10.1007/s00223-004-0227-5

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  99 in total

1.  Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans.

Authors:  Ling Lu; Hongguang Sheng; Huaixing Li; Wei Gan; Chen Liu; Jingwen Zhu; Ruth J F Loos; Xu Lin
Journal:  Hum Genet       Date:  2011-10-05       Impact factor: 4.132

2.  Vitamin D and Cardiovascular Disease: Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox?

Authors:  Samuel M Kim; Pamela L Lutsey; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-01-21

Review 3.  The emerging role of vitamin D binding protein in multiple sclerosis.

Authors:  Giulio Disanto; Sreeram V Ramagopalan; Andrea E Para; Lahiru Handunnetthi
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

4.  Free 25-Hydroxyvitamin D Concentrations in Cystic Fibrosis.

Authors:  Moon Jeong Lee; Malcolm D Kearns; Ellen M Smith; Li Hao; Thomas R Ziegler; Jessica A Alvarez; Vin Tangpricha
Journal:  Am J Med Sci       Date:  2015-11       Impact factor: 2.378

5.  The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.

Authors:  N Inoue; M Watanabe; N Ishido; Y Katsumata; T Kagawa; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

6.  Vitamin D status of patients with early inflammatory arthritis.

Authors:  Young-Eun Park; Bo-Hyun Kim; Seung-Geun Lee; Eun-Kyung Park; Ji-Heh Park; Sun-Hee Lee; Geun-Tae Kim
Journal:  Clin Rheumatol       Date:  2014-04-10       Impact factor: 2.980

7.  Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers.

Authors:  Thomas O Carpenter; Jane H Zhang; Esteban Parra; Bruce K Ellis; Christine Simpson; William M Lee; Jody Balko; Lei Fu; Betty Y-L Wong; David E C Cole
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

8.  Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Ruth C Travis; Francesca L Crowe; Naomi E Allen; Paul N Appleby; Andrew W Roddam; Anne Tjønneland; Anja Olsen; Jakob Linseisen; Rudolf Kaaks; Heiner Boeing; Janine Kröger; Antonia Trichopoulou; Vardis Dilis; Dimitrios Trichopoulos; Paolo Vineis; Domenico Palli; Rosario Tumino; Sabina Sieri; H Bas Bueno-de-Mesquita; Fränzel J B van Duijnhoven; María-Dolores Chirlaque; Aurelio Barricarte; Nerea Larrañaga; Carlos A González; Marcial V Argüelles; Maria-José Sánchez; Pär Stattin; Göran Hallmans; Kay-Tee Khaw; Sheila Bingham; Sabina Rinaldi; Nadia Slimani; Mazda Jenab; Elio Riboli; Timothy J Key
Journal:  Am J Epidemiol       Date:  2009-04-09       Impact factor: 4.897

9.  Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface.

Authors:  Boris Novakovic; Mandy Sibson; Hong Kiat Ng; Ursula Manuelpillai; Vardhman Rakyan; Thomas Down; Stephan Beck; Thierry Fournier; Danielle Evain-Brion; Eva Dimitriadis; Jeffrey M Craig; Ruth Morley; Richard Saffery
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

10.  Vitamin D binding protein genotype and osteoporosis.

Authors:  Yue Fang; Joyce B J van Meurs; Pascal Arp; Johannes P T van Leeuwen; Albert Hofman; Huibert A P Pols; André G Uitterlinden
Journal:  Calcif Tissue Int       Date:  2009-06-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.